SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.

2.

Glioblastoma treatment breakthrough shows promise

3.

How the metastasis of cancer is driven by cellular plasticity.

4.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

5.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot